Resources

Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042499/

Neuropsychological and psychiatric outcomes in encephalitis: A multi-centre case-control study February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094865/

18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968877/

Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146067/

Neurological Syndromes Associated with Anti-GAD Antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279468/

Early Bortezomib Therapy for Refractory Anti-NMDA Receptor Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118211/